• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes' B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.Dukes' B和C期直肠癌经腹会阴切除术和保留括约肌切除术的生存及治疗失败分析。NSABP临床试验报告。国家外科辅助乳腺和肠道项目
Ann Surg. 1986 Oct;204(4):480-9. doi: 10.1097/00000658-198610000-00016.
2
[Low anterior resection in the curative surgical treatment of rectal cancer].[直肠癌根治性手术治疗中的低位前切除术]
Ann Ital Chir. 1990 Nov-Dec;61(6):625-30; discussion 630-1.
3
Middle and lower third rectum carcinoma: sphincter saving or abdominoperineal resection?中下段直肠癌:保留括约肌还是腹会阴联合切除术?
Eur J Surg Oncol. 1995 Jun;21(3):265-8. doi: 10.1016/s0748-7983(95)91393-9.
4
[Low anterior resection in the curative surgical treatment of rectal cancer].[直肠癌根治性手术治疗中的低位前切除术]
Ann Ital Chir. 1992 May-Jun;63(3):271-7.
5
Coloanal anastomosis for distal third rectal cancer: prospective study of oncologic results.远端三分之一直肠癌的结肠肛管吻合术:肿瘤学结果的前瞻性研究
Dis Colon Rectum. 1999 Oct;42(10):1272-5. doi: 10.1007/BF02234212.
6
A comparison of stapled and handsewn anastomoses in patients undergoing resection for Dukes' B and C colorectal cancer. An analysis of disease-free survival and survival from the NSABP prospective clinical trials.对接受Dukes' B期和C期结直肠癌切除术患者的吻合器吻合术和手工缝合吻合术进行比较。对NSABP前瞻性临床试验中的无病生存期和总生存期进行分析。
Dis Colon Rectum. 1986 May;29(5):344-50. doi: 10.1007/BF02554128.
7
An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Duke's B and C rectal carcinoma. A report of the NSABP clinical trials.杜克B期和C期直肠癌经腹会阴切除术和保肛切除术后的生存及治疗失败分析。NSABP临床试验报告。
Ann Surg. 1987 Aug;206(2):224-6.
8
Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.术前放化疗及保留括约肌切除术治疗直肠下1/3段T3期癌
Ann Surg. 2001 Nov;234(5):633-40. doi: 10.1097/00000658-200111000-00008.
9
En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer.直肠癌手术治疗中的整块盆腔淋巴结清扫与保留括约肌
Ann Surg. 1986 Apr;203(4):426-33. doi: 10.1097/00000658-198604000-00015.
10
Long-term results of laparoscopic versus open resections for rectal cancer for 124 unselected patients.124例未经挑选的患者接受腹腔镜与开腹直肠癌切除术的长期结果。
Surg Endosc. 2003 Oct;17(10):1530-5. doi: 10.1007/s00464-002-8874-y. Epub 2003 Jul 21.

引用本文的文献

1
Lone-Star retractor perineal exposure method for laparoscopic abdominal perineal resection of rectal cancer.用于腹腔镜直肠癌腹会阴联合切除术的单星牵开器会阴暴露法
World J Gastrointest Surg. 2024 Aug 27;16(8):2528-2537. doi: 10.4240/wjgs.v16.i8.2528.
2
A novel perineal exposure method in laparoscopic abdominal perineal resection of rectal cancer: a case series study.一种新型的腹腔镜经会阴直肠癌腹会阴联合切除术会阴入路方法:一项病例系列研究。
BMC Surg. 2024 May 20;24(1):163. doi: 10.1186/s12893-024-02453-9.
3
Unveiling the profound advantages of total neoadjuvant therapy in rectal cancer: a trailblazing exploration.揭示全新辅助治疗在直肠癌中的深远优势:一次开创性探索。
Ann Surg Treat Res. 2023 Dec;105(6):341-352. doi: 10.4174/astr.2023.105.6.341. Epub 2023 Nov 29.
4
Partial mesorectal excision can be a primary option for middle rectal cancer: a propensity score-matched retrospective analysis.直肠系膜部分切除术可作为中低位直肠癌的主要治疗选择:一项倾向评分匹配的回顾性分析
Ann Coloproctol. 2024 Jun;40(3):253-267. doi: 10.3393/ac.2022.00689.0098. Epub 2023 Mar 31.
5
Management of Low Rectal Cancer Complicating Ulcerative Colitis: Proposal of a Treatment Algorithm.溃疡性结肠炎合并低位直肠癌的管理:一种治疗算法的建议
Cancers (Basel). 2021 May 13;13(10):2350. doi: 10.3390/cancers13102350.
6
Prognostic Impact of the Length of the Distal Resection Margin in Rectosigmoid Cancer: An Analysis of the JSCCR Database between 1995 and 2004.乙状结肠癌远端切缘长度的预后影响:对1995年至2004年间日本结直肠癌学会(JSCCR)数据库的分析
J Anus Rectum Colon. 2020 Apr 28;4(2):59-66. doi: 10.23922/jarc.2019-013. eCollection 2020.
7
Colorectal Cancer in the Elderly Patient: The Role of Neo-adjuvant Therapy.老年患者的结直肠癌:新辅助治疗的作用
Open Med (Wars). 2019 Aug 14;14:607-612. doi: 10.1515/med-2019-0068. eCollection 2019.
8
Abdominoperineal Resection for Rectal Cancer in the Twenty-First Century: Indications, Techniques, and Outcomes.二十一世纪直肠癌的腹会阴联合切除术:适应证、技术和结果。
J Gastrointest Surg. 2018 Aug;22(8):1477-1487. doi: 10.1007/s11605-018-3750-9. Epub 2018 Apr 16.
9
Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer.剂量递增放疗对复发性结直肠癌的疗效
Ann Coloproctol. 2016 Apr;32(2):66-72. doi: 10.3393/ac.2016.32.2.66. Epub 2016 Apr 30.
10
Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.外科医生对新辅助放化疗在直肠癌治疗中的应用及效果的观点:文献综述
Langenbecks Arch Surg. 2015 Aug;400(6):661-73. doi: 10.1007/s00423-015-1328-5. Epub 2015 Aug 7.

本文引用的文献

1
Anterior Resection for Malignant Lesions of the Upper Part of the Rectum and Lower Part of the Sigmoid.直肠上段和乙状结肠下段恶性病变的前切除术
Ann Surg. 1948 Sep;128(3):425-42. doi: 10.1097/00000658-194809000-00009.
2
The blood-supply to the sigmoid colon and rectum with reference to the technique of rectal resection with restoration of continuity.乙状结肠和直肠的血液供应与直肠切除并恢复连续性的技术相关。
Br J Surg. 1949 Oct;37(146):157-62. doi: 10.1002/bjs.18003714604.
3
RESULTS OF LIGATION OF INFERIOR MESENTERIC ARTERY AT THE AORTA IN RESECTIONS OF CARCINOMA OF THE DESCENDING AND SIGMOID COLON AND RECTUM.降结肠、乙状结肠及直肠癌切除术中在主动脉处结扎肠系膜下动脉的结果
Surg Gynecol Obstet. 1965 May;120:1031-6.
4
Anterior resection for carcinoma of the rectum and rectosigmoid area.直肠及直肠乙状结肠交界处癌的前切除术。
Ann Surg. 1961 Dec;154(6):961-6.
5
Five year survival after anterior resection for carcinoma of the rectum and rectosigmoid.直肠癌和直肠乙状结肠癌前切除术后的五年生存率。
Surg Gynecol Obstet. 1958 Jun;106(6):695-8.
6
Long term results of restorative resection and total excision for carcinoma of the middle third of the rectum.直肠中三分之一段癌行根治性切除和全切除的长期结果
Surg Gynecol Obstet. 1982 Jun;154(6):833-7.
7
The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum.直肠癌根治性前切除术后远端切缘范围与生存率及局部复发率之间的关系。
Ann Surg. 1983 Aug;198(2):159-63. doi: 10.1097/00000658-198308000-00008.
8
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival.直肠癌远端切除5厘米规则的重新评估:一项关于远端壁内扩散及患者生存率的研究
Br J Surg. 1983 Mar;70(3):150-4. doi: 10.1002/bjs.1800700305.
9
The relationship of depth of penetration and tumor size to the number of positive nodes in Dukes C colorectal cancer.杜克C期结肠癌中肿瘤浸润深度和肿瘤大小与阳性淋巴结数量的关系。
Cancer. 1984 Jun 15;53(12):2707-12. doi: 10.1002/1097-0142(19840615)53:12<2707::aid-cncr2820531225>3.0.co;2-r.
10
Survival and recurrence after sphincter saving resection and abdominoperineal resection for carcinoma of the middle third of the rectum.直肠中三分之一段癌行保肛切除术和腹会阴联合切除术的生存及复发情况。
Br J Surg. 1984 Apr;71(4):278-82. doi: 10.1002/bjs.1800710409.

Dukes' B和C期直肠癌经腹会阴切除术和保留括约肌切除术的生存及治疗失败分析。NSABP临床试验报告。国家外科辅助乳腺和肠道项目

An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes' B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.

作者信息

Wolmark N, Fisher B

出版信息

Ann Surg. 1986 Oct;204(4):480-9. doi: 10.1097/00000658-198610000-00016.

DOI:10.1097/00000658-198610000-00016
PMID:3532972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1251324/
Abstract

Abdominoperineal resections for rectal carcinoma are being performed with decreasing frequency in favor of sphincter-saving resections. It remains, however, to be unequivocally demonstrated that sphincter preservation has not resulted in compromised local disease control, disease-free survival, and survival. Accordingly, it is the specific aim of this endeavor to compare local recurrence, disease-free survival, and survival in patients with Dukes' B and C rectal cancer undergoing curative abdominoperineal resection or sphincter-saving resection. For the purpose of this study, 232 patients undergoing abdominoperineal resection and 181 subjected to sphincter-saving resections were available for analysis from an NSABP randomized prospective clinical trial designed to ascertain the efficacy of adjuvant therapy in rectal carcinoma (protocol R-01). The mean time on study was 48 months. Analyses were carried out comparing the two operations according to Dukes' class, the number of positive nodes, and tumor size. The only significant differences in disease-free survival and survival were observed for the cohort characterized by greater than 4 positive nodes and were in favor of patients treated with sphincter-saving resections. A patient undergoing sphincter-saving resection was 0.62 times as likely to sustain a treatment failure as a similar patient undergoing abdominoperineal resection (p = 0.07) and 0.49 times as likely to die (p = 0.02). The inability to demonstrate an attenuated disease-free survival and survival for patients treated with sphincter-saving resection was in spite of an increased incidence of local recurrence (anastomotic and pelvic) observed for the latter operation when compared to abdominoperineal resection (13% vs. 5%). A similar analysis evaluating the length of margins of resection in patients undergoing sphincter-preserving operations indicated that treatment failure and survival were not significantly different in patients whose distal resection margins were less than 2 cm, 2-2.9 cm, or greater than or equal to 3 cm. If any trend was observed, it appeared that patients with smaller resection margins had a slightly prolonged survival (p = 0.10). This observation was present in spite of the fact that local recurrence as a first site of treatment failure was greater in the group with less than 2 cm that it was in the greater than or equal to 3 cm category, 22% versus 12%. This increased local recurrence rate in the population with smaller margins was not translated into an in crease in overall treatment failure and had absolutely no influence on survival. It is suggested that local recurrence serves as a marker of distant disease.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

由于保肛手术更受青睐,直肠癌腹会阴联合切除术的实施频率正在降低。然而,仍需明确证明保肛手术不会导致局部疾病控制、无病生存期和总生存期受到影响。因此,本研究的具体目的是比较接受根治性腹会阴联合切除术或保肛手术的 Dukes' B 期和 C 期直肠癌患者的局部复发率、无病生存期和总生存期。在一项旨在确定辅助治疗对直肠癌疗效的 NSABP 随机前瞻性临床试验(方案 R - 01)中,有 232 例接受腹会阴联合切除术的患者和 181 例接受保肛手术的患者可供分析。研究的平均时间为 48 个月。根据 Dukes' 分期、阳性淋巴结数量和肿瘤大小对这两种手术进行了比较分析。在无病生存期和总生存期方面,唯一显著的差异出现在阳性淋巴结大于 4 个的队列中,且保肛手术治疗的患者更具优势。接受保肛手术的患者发生治疗失败的可能性是接受类似腹会阴联合切除术患者的 0.62 倍(p = 0.07),死亡可能性是其 0.49 倍(p = 0.02)。尽管与腹会阴联合切除术相比,保肛手术观察到局部复发(吻合口和盆腔)发生率增加(13% 对 5%),但仍未能证明保肛手术治疗的患者无病生存期和总生存期缩短。一项评估保肛手术患者切缘长度的类似分析表明,远端切缘小于 2 cm、2 - 2.9 cm 或大于或等于 3 cm 的患者,治疗失败率和总生存期无显著差异。如果观察到任何趋势,似乎切缘较小的患者生存期略有延长(p = 0.10)。尽管切缘小于 2 cm 的组中局部复发作为首次治疗失败部位的发生率高于切缘大于或等于 3 cm 的组(22% 对 12%),但仍有此观察结果。切缘较小人群中局部复发率的增加并未转化为总体治疗失败率的增加,且对生存期绝对没有影响。提示局部复发可作为远处疾病的一个标志。(摘要截断于 400 字)